Metabolic dysfunction in pcos: Relationship to obstructive sleep apnea.
1Section of Endocrinology, Diabetes, and Metabolism, The University of Chicago, 5841 S. Maryland Ave., Mail Code 1027, Chicago, IL 60637, USA. dehrmann@medicine.bsd.uchicago.edu
Steroids
|December 20, 2011
Summary
Polycystic ovary syndrome (PCOS) is linked to obstructive sleep apnea (OSA), a condition causing metabolic issues. Women with PCOS have a significantly higher risk of developing OSA, exacerbating their metabolic derangements.
Area of Science:
- Endocrinology
- Sleep Medicine
- Metabolic Disorders
Background:
- Polycystic ovary syndrome (PCOS) affects 5-8% of women, characterized by hyperandrogenism, obesity, and insulin resistance.
- PCOS is associated with high rates of impaired glucose tolerance (30-40%) and type 2 diabetes (up to 10%).
- Chronic sleep deprivation is increasingly recognized as a risk factor for metabolic derangements similar to those in PCOS.
Purpose of the Study:
- To explore the connection between obstructive sleep apnea (OSA) and polycystic ovary syndrome (PCOS).
- To investigate the disproportionately high prevalence of OSA in women with PCOS.
- To address the causes and consequences of OSA in women diagnosed with PCOS.
Main Methods:
- Literature review and synthesis of existing research on PCOS, OSA, and metabolic health.
- Comparative analysis of OSA prevalence in women with and without PCOS.
- Examination of the causal links between OSA and metabolic dysfunction.
Main Results:
- Obstructive sleep apnea (OSA) is causally linked to insulin resistance, glucose intolerance, dyslipidemia, and hypertension, independent of BMI.
- Women with PCOS have a 5- to 10-fold higher risk of OSA compared to similarly obese women without PCOS.
- The manuscript addresses the underlying causes and resulting consequences of OSA in the PCOS population.
Conclusions:
- Obstructive sleep apnea (OSA) is a significant, underrecognized comorbidity in women with polycystic ovary syndrome (PCOS).
- The high prevalence of OSA in PCOS likely contributes to the metabolic complications observed in the disorder.
- Further research and clinical attention are warranted to manage OSA in women with PCOS to improve metabolic outcomes.
More Related Videos
05:34Auricular Acupuncture as a Traditional Chinese Medicine Therapy for Chronic Obstructive Pulmonary Disease Combined with Sleep Disorders
Published on: August 18, 2023
07:54Drug-Induced Sleep Endoscopy (DISE) with Target Controlled Infusion (TCI) and Bispectral Analysis in Obstructive Sleep Apnea
Published on: December 6, 2016
Related Concept Videos
01:21Sleep Apnea
Sleep apnea is a condition where breathing stops intermittently during sleep, often leading to significant health issues. Each episode can last from 10 to 20 seconds or more and is frequently accompanied by a brief arousal from sleep. This disturbance, largely unnoticed by the individual, can lead to severe daytime fatigue. Commonly, individuals seek help after being informed by their partners about loud snoring and noticeable breathing pauses during sleep.
The condition is more prevalent among...
The condition is more prevalent among...
01:20Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
01:24Sleep-Wake Cycles
Sleep is an essential physiological process vital to maintaining overall well-being. The reticular activating system (RAS), a network of neurons in the brainstem, regulates wakefulness and sleep. While it may seem passive, sleep consists of distinct cycles, each with its unique characteristics and functions. Two key sleep phases are non-rapid eye movement (NREM) and rapid eye movement (REM).
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
01:13Insufficient Sleep and Sleep Deprivation
Insufficient sleep refers to not getting the recommended amount of sleep for optimal functioning, even if it's just slightly less than needed. Sleep insufficiency may occur due to lifestyle choices, such as staying up late for social events or work, resulting in routinely getting less sleep than required. For example, consistently sleeping 6 hours when the body needs 7-9 hours can lead to cumulative effects on health and well-being.
Sleep deprivation is a more severe form of sleep loss...
Sleep deprivation is a more severe form of sleep loss...
01:24Obesity
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...